Zobrazeno 1 - 10
of 75
pro vyhledávání: '"S. Francis"'
Autor:
Iqbal J; Cardiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Chamberlain J; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Alfaidi M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Hughes M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Alizadeh T; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Casbolt H; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Evans P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Mann B; Department of Chemistry, University of Sheffield, Sheffield, United Kingdom ; and., Motterlini R; Faculty of Medicine, University Paris-Est, Champs-sur-Marne, France ., Francis S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Gunn J; Cardiology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2021 Nov 01; Vol. 78 (5), pp. e656-e661.
Autor:
Bageghni SA; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Hemmings KE; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Yuldasheva NY; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Maqbool A; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Gamboa-Esteves FO; Leeds Institute of Cancer and Pathology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Humphreys NE; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Jackson MS; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Denton CP; Institute of Immunity and Transplantation, Centre for Rheumatology and Connective Tissue Diseases, University College London and Royal Free Hospital, London, United Kingdom., Francis S; Department of Infection, Immunity & Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, United Kingdom., Porter KE; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Ainscough JF; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Pinteaux E; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Drinkhill MJ; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom., Turner NA; Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, United Kingdom.
Publikováno v:
JCI insight [JCI Insight] 2019 Aug 08; Vol. 5. Date of Electronic Publication: 2019 Aug 08.
Autor:
Eduardo Marbán, Linda Marbán, Rachel R Smith, Glenn Kowalchuk, Tarun Chakravarty, Thomas J. Povsic, Janice M. Pogoda, Konstantinos Malliaras, Gary S. Francis, Anthony N. DeMaria, Deborah D. Ascheim, Dean J. Kereiakes, Mohammad R. Ostovaneh, Joao A.C. Lima, Richard A. Schatz, Frank V. Aguirre, Timothy D. Henry, Raj Makkar, Jay H. Traverse
Publikováno v:
European Heart Journal. 41:3451-3458
Aims Cardiosphere-derived cells (CDCs) are cardiac progenitor cells that exhibit disease-modifying bioactivity in various models of cardiomyopathy and in previous clinical studies of acute myocardial infarction (MI), dilated cardiomyopathy, and Duche
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design
Autor:
Gary S. Francis, Anthony N. DeMaria, Linda Marbán, Jay H. Traverse, Deborah D. Ascheim, Joao A.C. Lima, Rachel R Smith, Thomas J. Povsic, Tarun Chakravarty, Janice M. Pogoda, Richard A. Schatz, Timothy D. Henry, Raj Makkar
Publikováno v:
Cell Transplantation, Vol 26 (2017)
Autologous cardiosphere-derived cells (CDCs) were the first therapeutic modality to demonstrate myocardial regeneration with a decrease in scar size and an increase in viable, functional tissue. Widespread applicability of autologous CDC therapy is l
Autor:
John J.V. McMurray, Kevin L. Thomas, W. Douglas Weaver, Eldrin F. Lewis, Marc A. Pfeffer, Gary S. Francis, Robert M. Califf, Eric J. Velazquez, L. Michael Prisant, Zhen Huang
Publikováno v:
Journal of the American College of Cardiology. 51:1865-1871
Objectives African Americans have a high incidence of heart failure (HF). Limited retrospective observational subgroup analyses of patients with left ventricular systolic dysfunction (LVSD) suggest marginal benefit of angiotensin-converting enzyme in
Autor:
Allan S. Jaffe, Jordi Ordóñez-Llanos, Robert H. Christenson, Alan H.B. Wu, Christopher P. Cannon, Fred S. Apple, Gary S. Francis, Johannes Mair, Alan B. Storrow, Jillian R. Tate, Jan Ravkilde, Wai (Wilson) Hong Tang, Mauro Panteghini, Robert L. Jesse, David A. Morrow, Franca Pagani, L. Kristin Newby
Publikováno v:
Clinical Chemistry. 53:547-551
a. Background In 1999, the National Academy of Clinical Biochemistry (NACB)1 published the first standards of laboratory practice addressing analytical and clinical recommendations for use of cardiac markers in coronary artery diseases (1). The objec
Autor:
Alan B. Storrow, Gary S. Francis, Robert H. Christenson, Christopher P. Cannon, Robert L. Jesse, Alan H.B. Wu, Fred S. Apple, Jan Ravkilde, Wilson Tang, L. Kristin Newby, David A. Morrow
Publikováno v:
Morrow, D A, Cannon, C P, Jesse, R L, Newby, L K, Ravkilde, J, Storrow, A B, Wu, A H B, Christenson, R H, Apple, F A, Francis, G & Tang, W 2007, ' National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes ', Clinical Chemistry, vol. 53, no. 4, pp. 552-574 .
a. definition of terms Acute coronary syndrome (ACS)1 refers to a constellation of clinical symptoms caused by acute myocardial ischemia (1)(2). Owing to their higher risk for cardiac death or ischemic complications, patients with ACS must be identif
Autor:
Anjli Maroo, Danielle M. Brennan, Gary S. Francis, W.H. Wilson Tang, Eric J. Topol, Steven R. Steinhubl, Ellen McErlean, Frederick Van Lente
Publikováno v:
American Heart Journal. 153:36-41
The utility of N-terminal pro-BNP (NT-proBNP) measurement as a prognostic marker during nonurgent percutaneous coronary intervention (PCI) has been suggested in several studies. The comparative prognostic values between NT-proBNP levels and left vent
Autor:
David M. Larson, Joseph P. Ornato, Michael J. Rosenberg, Timothy D. Henry, Gary S. Francis, Michael S. Cunningham, Mary Ann Peberdy, William J. Groh, James M Atkins, W. Douglas Weaver, Erik Magnus Ohman, Karl B. Kern, Robert Hong
Publikováno v:
Journal of the American College of Cardiology. 47:1339-1345
Despite substantial progress in the diagnosis and treatment of acute ST-segment elevation myocardial infarction (STEMI), implementation of this knowledge into routine clinical practice has been variable. It has become increasing clear that primary pe
Autor:
David Aguilar, Lars Køber, Hicham Skali, Scott D. Solomon, Marc A. Pfeffer, Sergei Varshavsky, Marc Henis, Jeffrey D. Leimberger, Christopher M. O'Connor, Yuri N. Belenkov, John J.V. McMurray, Robert M. Califf, Gary S. Francis, Eric J. Velazquez, Rafael Diaz, Jean-Lucien Rouleau
Publikováno v:
Circulation. 110:1572-1578
Background— A prior diagnosis of diabetes mellitus is associated with adverse outcomes after acute myocardial infarction (MI), but the risk associated with a new diagnosis of diabetes in this setting has not been well defined. Methods and Results